Aptinyx (NASDAQ:APTX) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Aptinyx (NASDAQ:APTXGet Rating) announced its quarterly earnings results on Thursday. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.02, Fidelity Earnings reports. During the same period in the prior year, the company posted ($0.22) EPS.

Shares of NASDAQ APTX traded up $0.10 during trading on Friday, reaching $0.70. 136,370 shares of the stock traded hands, compared to its average volume of 312,910. Aptinyx has a 52-week low of $0.57 and a 52-week high of $4.73. The company has a debt-to-equity ratio of 0.15, a current ratio of 20.18 and a quick ratio of 20.18. The company has a 50-day moving average of $1.78 and a 200-day moving average of $2.43. The stock has a market capitalization of $47.40 million, a P/E ratio of -0.59 and a beta of 1.46.

Several hedge funds and other institutional investors have recently modified their holdings of APTX. Royal Bank of Canada lifted its position in shares of Aptinyx by 244.5% during the 2nd quarter. Royal Bank of Canada now owns 9,288 shares of the company’s stock valued at $26,000 after buying an additional 6,592 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Aptinyx by 5.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 123,937 shares of the company’s stock valued at $331,000 after buying an additional 6,133 shares during the last quarter. Charles Schwab Investment Management Inc. purchased a new position in shares of Aptinyx during the 4th quarter valued at $54,000. Millennium Management LLC lifted its position in shares of Aptinyx by 19.7% during the 4th quarter. Millennium Management LLC now owns 1,246,945 shares of the company’s stock valued at $3,329,000 after buying an additional 205,553 shares during the last quarter. Finally, Susquehanna International Group LLP lifted its position in shares of Aptinyx by 56.8% during the 4th quarter. Susquehanna International Group LLP now owns 243,275 shares of the company’s stock valued at $650,000 after buying an additional 88,141 shares during the last quarter. 55.97% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts recently issued reports on the company. William Blair downgraded Aptinyx from an “outperform” rating to a “market perform” rating in a report on Thursday, April 7th. Zacks Investment Research downgraded Aptinyx from a “buy” rating to a “hold” rating in a research note on Friday, April 22nd. Cantor Fitzgerald reduced their price objective on Aptinyx from $11.00 to $5.00 and set an “overweight” rating for the company in a research note on Friday, April 8th. HC Wainwright reduced their price objective on Aptinyx from $8.00 to $2.00 and set a “buy” rating for the company in a research note on Thursday, April 14th. Finally, Truist Financial reduced their price objective on Aptinyx from $12.00 to $5.00 and set a “buy” rating for the company in a research note on Friday, April 8th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, Aptinyx presently has an average rating of “Buy” and an average price target of $3.88.

About Aptinyx (Get Rating)

Aptinyx Inc, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia.

Read More

Earnings History for Aptinyx (NASDAQ:APTX)

Receive News & Ratings for Aptinyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptinyx and related companies with MarketBeat.com's FREE daily email newsletter.